3-amino-9,13b-dihydro-1H-benz(c,f)imidazo(1,5a)azepine,
epinastine,
epinastine hydrochloride,
Flurinol,
WAL 80,
WAL 801,
WAL 801 CL,
WAL 801CL,
WAL-80 Cl,
Epinastine hydrochloride,
Epinastine HCl,
108929-04-0,
Alesion,
Elestat,
Epinastin HCl,
WAL-801CL,
80012-44-8,
Epinastine monohydrochloride,
WAL 801 CL,
WAL 801CL,
Epinastine hydrochloride [JAN],
Relestat,
MFCD00933434,
9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride,
3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine monohydrochloride,
DSSTox_CID_26502,
DSSTox_RID_81671,
DSSTox_GSID_46502,
C16H16ClN3,
Epinastine hydrochloride (JAN),
9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine Hydrochloride,
9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride,
IH-Dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, monohydrochloride,
CHEBI:51037,
CAS-108929-04-0,
NCGC00165791-02,
Flurinol,
epinastine-hcl,
(13bRS)-9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride,
Alesion (TN),
Elestat (TN),
epinastin hydrochloride,
PubChem1940,
AC1L4HSC,
WAL-801CL HCl,
C16H15N3.HCl,
SCHEMBL122749,
CHEMBL1200491,
DTXSID1046502,
CTK8B3730,
VKXSGUIOOQPGAF-UHFFFAOYSA-N,
HMS3652N21,
BCP12119,
EX-A1004,
Tox21_112263,
Tox21_500501,
ANW-43039,
DE-114,
s4253,
AKOS015967222,
Tox21_112263_1,
AC-1491,
CCG-221805,
KS-1159,
LP00501,
RTR-002009,
NCGC00165791-04,
NCGC00261186-01,
AN-14853,
BC220918,
LS-60567,
TR-002009,
E0799,
FT-0631049,
FT-0700527,
SW220223-1,
D01713,
Epinastine hydrochloride, >=98% (HPLC), solid,
J-002209,
3-Amino-9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepine Hydrochloride,
Epinastine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
IH-Dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, hydrochloride,
9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine, monohydrochloride,
Epinastine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
Epinastine hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard,
epinastine,
Epinastinehydrochloride,
UNII-GFM415S5XL,
C16H15N3.xClH,
GFM415S5XL,
1,1,7,7-Tetramethyljulolidine,
C16-H15-N3.Cl-H,
CID157313,
80012-43-7,
9,13b-Dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride,
(+/-)-3-Amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride,
1H-Dibenz[cf]imidazo[15-a]azepin-3-amine913b-dihydro-monohydrochloride (9CI),
1H-dibenzo [c, f] imidazo [1,5-un azepin]-3-amina, 9,13 b-dihidro-,clorhidrato (1:1),
1H-dibenzo [c, f] imidazo [1,5-un azepin]-3-amina, 9,13 b-dihidro-, monoclorhidrato (9CI),